Practitioner attitudes to clozapine initiation

Practitioner attitudes to clozapine initiation

Veure altres versions (1)

Objective: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia. It is recommended as third-line treatment for schizophrenia in national and local guidelines. Despite this, it is underutilised. This survey aimed to clarify barriers to prescribing and elucidate factors...

Descripció completa

Dades bibliogràfiques
Autors principals:	Gee, S, Vergunst, F, Howes, O, Taylor, D
Format:	Journal article
Idioma:	English
Publicat:	Blackwell Publishing Ltd 2014

Ítems similars

Practitioner attitudes to clozapine initiation.
per: Gee, S, et al.
Publicat: (2013)

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation.
per: Howes, O, et al.
Publicat: (2012)

Community Clozapine Initiation Practice
per: Kabir Yisa, et al.
Publicat: (2024-06-01)

Clinician’s attitude towards clozapine prescription
per: O. Brugue, et al.
Publicat: (2023-03-01)

Differences between physicians' and nurse practitioners' viewpoints on reasons for clozapine underprescription
per: Cynthia Okhuijsen‐Pfeifer, et al.
Publicat: (2019-07-01)

The effect of COVID-19 on absolute neutrophil counts in patients taking clozapine
per: Siobhan Gee, et al.
Publicat: (2020-07-01)

Experience with and attitude toward clozapine use among patients receiving clozapine on long term and their caregivers
per: Sandeep Grover, et al.
Publicat: (2023-11-01)

Attitude and knowledge towards clozapine among outpatients prescribed clozapine in Durban, KwaZulu-Natal
per: Saeeda Paruk, et al.
Publicat: (2018-09-01)

The Effect of Clozapine on Tremor in Patients with Parkinson’s Disease who were Initiated Clozapine For Psychotic Symptoms
per: Emel Oğuz Akarsu, et al.
Publicat: (2013-12-01)

Birth weight, leptin and adiponectin in patients initiating clozapine
per: L. Ilzarbe, et al.
Publicat: (2024-04-01)

Initiating clozapine treatment service and characteristics of clozapine-treated patients in a general hospital in Addis Ababa, Ethiopia
per: Solomon Teferra
Publicat: (2020-06-01)

A Case Report of Complex Clozapine Initiation Despite Contraindications
per: G. Dumais-Lévesque, et al.
Publicat: (2023-03-01)

Management of clozapine treatment during the COVID-19 pandemic
per: Siobhan Gee, et al.
Publicat: (2020-05-01)

Clozapine clinical toolkit optimizes inpatient clozapine monitoring
per: Brooke Gessner, PharmD, ACPR, et al.
Publicat: (2024-04-01)

Reasons for admission to a general medical hospital for patients taking clozapine
per: Siobhan Gee, et al.
Publicat: (2022-12-01)

Inflammatory response to clozapine in the absence of myocarditis: case report
per: Patrick Davey, et al.
Publicat: (2016-05-01)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
per: Ebenezer Oloyede, et al.
Publicat: (2023-06-01)

Medical, Psychiatric, and Sociodemographic Predictors of Clozapine Initiation at an Academic Medical Center
per: Kathleen Shangraw, et al.
Publicat: (2024-09-01)

Clozapine cessation
per: H. Ktari, et al.
Publicat: (2022-06-01)

Clozapine in the elderly: Concerns and challengesClozapine in the elderly: Concerns and challenges
per: Sandeep Grover
Publicat: (2023-01-01)

Intramuscular clozapine in the acute medical hospital: Experiences from a liaison psychiatry team
per: Siobhan Gee, et al.
Publicat: (2021-05-01)

Clozapine and urinary incontinence
per: A. Osca Oliver, et al.
Publicat: (2022-06-01)

Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide
per: Edward Silva, et al.
Publicat: (2020-06-01)

Multiorgan eosinophilic infiltration after initiation of clozapine therapy: a case report
per: Dorota Marchel, et al.
Publicat: (2017-07-01)

Mrna vaccination under clozapine treatment
per: P. Argitis, et al.
Publicat: (2022-06-01)

Repurposing clozapine in psychosis
per: Oloyede, E
Publicat: (2024)

Clozapine-induced Delirium
per: Fatima Shamla, et al.
Publicat: (2023-06-01)

Clozapine-induced hypertension
per: Vrushti Bharat Patil, et al.
Publicat: (2022-01-01)

Clozapine use in adolescents
per: Samir Kumar Praharaj
Publicat: (2017-01-01)

Clozapine for mitochondrial psychosis
per: Josef Finsterer, et al.
Publicat: (2017-03-01)

Clozapine prescribing in COVID-19 positive medical inpatients: a case series
per: Matthew Butler, et al.
Publicat: (2020-09-01)

Delay in Clozapine Initiation in Patients with Treatment-Resistance Schizophrenia Presenting Tertiary Psychiatric Facilities
per: Asad Ullah Jan, et al.
Publicat: (2024-06-01)

Effective and underprescribed: what about clozapine?
per: Helge H.O. Müller
Publicat: (2017-10-01)

Combining ECT and clozapine in the treatment of clozapine-refractory schizophrenia and schizoaffective disorder – a pilot study
per: L Koen, et al.
Publicat: (2008-12-01)

Ethnic inequalities in treatment with clozapine
per: D. Fonseca De Freitas, et al.
Publicat: (2022-06-01)

Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN)
per: Marte Z. van der Horst, et al.
Publicat: (2025-02-01)

Clozapine Monitoring in Older Adults: An Audit Evaluating Compliance With Clozapine Guidelines in Community Settings
per: Godwin Tong, et al.
Publicat: (2024-06-01)

Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients
per: Hana Hribkova, et al.
Publicat: (2022-02-01)

Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
per: Victoria Rodriguez, et al.
Publicat: (2020-05-01)

Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
per: Claas-Frederik Johannsen, et al.
Publicat: (2022-03-01)